» Articles » PMID: 2454244

Use of Immunocytochemistry of Progesterone and Estrogen Receptors for Endometrial Dating

Overview
Specialty Endocrinology
Date 1988 Jul 1
PMID 2454244
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Endometrial progesterone and estrogen receptors were studied by immunocytochemistry using monoclonal antibodies during the menstrual cycle in normal women. We initially compared immunocytochemical staining of progesterone and estradiol receptors on endometrial fragments obtained by either aspiration or endometrial biopsy and found that immunocytochemistry could be performed easily on tissue obtained in either way. The immunocytochemical studies showed that the concentration and distribution of receptors changed markedly during the normal menstrual cycle. These changes were distributed in three characteristic phases. During phase I, corresponding to the midfollicular period (days 7-8), a small proportion (25%) of stromal and glandular cells stained positively for the progesterone receptor, whereas estrogen receptor staining was more intense and more frequent (50% of cells). Phase II, which included both the late follicular and early luteal periods (days 9-19), was characterized by a marked staining of progesterone receptors in the majority of glandular cells (75%) and somewhat less abundant and less frequent staining in stromal cells (50%). Estrogen receptor staining was present in about half of the glandular and stromal cells. Phase III, the mid- and late luteal period (days 21-27), was characterized by the disappearance of estrogen and progesterone receptor staining in glandular cells, although faint staining for both receptors was found in stromal cells. These variations in progesterone receptor staining are potentially useful for determining the effect of progesterone on endometrial maturation.

Citing Articles

Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics.

Marquardt R, Tran D, Lessey B, Rahman M, Jeong J Endocr Rev. 2023; 44(6):1074-1095.

PMID: 37409951 PMC: 10638603. DOI: 10.1210/endrev/bnad020.


Endogenous progesterone in unexplained infertility: a systematic review and meta-analysis.

Raperport C, Chronopoulou E, Homburg R, Khan K, Bhide P J Assist Reprod Genet. 2022; 40(3):509-524.

PMID: 36572790 PMC: 10033797. DOI: 10.1007/s10815-022-02689-5.


Progesterone: The Key Factor of the Beginning of Life.

Bulletti C, Bulletti F, Sciorio R, Guido M Int J Mol Sci. 2022; 23(22).

PMID: 36430614 PMC: 9692968. DOI: 10.3390/ijms232214138.


Pathological diagnosis of thoracic endometriosis.

Keijzer S, Oosterhuis W, Hazelbag H, Meuleman T BMJ Case Rep. 2021; 14(8).

PMID: 34404651 PMC: 8372794. DOI: 10.1136/bcr-2021-243258.


Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.

Islam M, Afrin S, Jones S, Segars J Endocr Rev. 2020; 41(5).

PMID: 32365199 PMC: 8659360. DOI: 10.1210/endrev/bnaa012.